Spero Therapeutics, Inc.(NasdaqGS:SPRO) dropped from Russell 3000E Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | +3.01% |
|
+0.74% | -6.80% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
May. 15 | Spero Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.80% | 73.96M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Spero Therapeutics, Inc.(NasdaqGS: SPRO) dropped from Russell 3000E Growth Index